Immune Oncology Research Institute
6 clinical trials · Sponsor
◉ Watch Immune Oncology Research Institute
| Record | Firm | Date |
|---|---|---|
| Cardiac Angiosarcoma International Registry (NCT06715579) | Immune Oncology Research Institute | 2025-05-01 |
| Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008) (NCT06322108) | Immune Oncology Research Institute | 2024-06-13 |
| Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMONC0001) (NCT05891821) | Immune Oncology Research Institute | 2023-09-01 |
| Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With Dexamethasone (NCT05872893) | Immune Oncology Research Institute | 2023-06-27 |
| Rare Embryonal Tumors of the Central Nervous System: International Registry (NCT05711992) | Immune Oncology Research Institute | 2023-02-01 |
| Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry (NCT05430971) | Immune Oncology Research Institute | 2022-07-01 |
Track Immune Oncology Research Institute automatically
Every clearance here is in the API, with alerts when new ones post.